selumetinib
Showing 26 - 50 of 50
NSCLC (NSCLC) Trial in Tainan, Taipei (selumetinib)
Completed
- Non-small Cell Lung Cancer (NSCLC)
- selumetinib
-
Tainan, Taiwan
- +2 more
Jul 9, 2018
Malignant Tumor of Respiratory and Intrathoracic Organ Carcinoma, Advanced Lung Cancer, Recurrent Nonsmall Cell Lung Cancer
Withdrawn
- Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma
- +2 more
- Selumetinib
- +2 more
- (no location specified)
Mar 14, 2018
Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV Trial in United Kingdom (selumetinib, gemcitabine, cisplatin)
Completed
- Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
- selumetinib
- +4 more
-
Glasgow, United Kingdom
- +3 more
Mar 12, 2018
Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial
Completed
- Recurrent Thyroid Gland Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- Selumetinib
-
Tampa, Florida
- +5 more
Dec 2, 2016
Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Ocular Melanoma With Extraocular Extension Trial in Canada, United
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer Trial in Kashiwa Shi, Chuo Ku (Cisplatin, Gemcitabine,
Terminated
- Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
- Cisplatin
- +2 more
-
Kashiwa Shi, Chiba, Japan
- +1 more
May 5, 2016
Biliary Tract Tumors, Cholangiocarcinoma, Gallbladder Tumors Trial in London, Manchester (selumetinib, gemcitabine, cisplatin)
Completed
- Biliary Tract Neoplasms
- +2 more
- selumetinib
- +2 more
-
London, United Kingdom
- +2 more
May 11, 2016
Liver and Intrahepatic Biliary Tract Cancer, Recurrent Extrahepatic Bile Duct Cancer, Unresectable Extrahepatic Bile Duct Cancer
Completed
- Liver and Intrahepatic Biliary Tract Cancer
- +2 more
- selumetinib
- laboratory biomarker analysis
-
Tampa, Florida
- +6 more
Mar 22, 2016
Adult Solid Tumor Trial in Baltimore (biological, other, drug)
Completed
- Adult Solid Neoplasm
- Cixutumumab
- +3 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Jan 22, 2016
Solid Tumours Trial in Overland Park (Selumetinib, Moxifloxacin, selumetinib )
Completed
- Solid Tumours
- Selumetinib
- +2 more
-
Overland Park, KansasResearch Site
Oct 7, 2015
Recurrent Adult Diffuse Large Cell Lymphoma Trial in United States (Laboratory Biomarker Analysis, Selumetinib)
Terminated
- Recurrent Adult Diffuse Large Cell Lymphoma
- Laboratory Biomarker Analysis
- Selumetinib
-
Chicago, Illinois
- +15 more
Jan 4, 2016
Solid Tumours Trial in Overland Park (selumetinib, itraconazole, fluconazole)
Completed
- Solid Tumours
- selumetinib
- +2 more
-
Overland Park, KansasResearch Site
Jun 29, 2015
Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in United
Completed
- Recurrent Adult Soft Tissue Sarcoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Beverly Hills, California
- +7 more
Sep 4, 2015
Solid Tumours Trial in Orlando (selumetinib)
Completed
- Solid Tumours
- selumetinib
-
Orlando, FloridaResearch Site
Jun 29, 2015
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3), MDS Trial in Chicago (selumetinib)
Completed
- Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
- +5 more
- selumetinib
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jul 6, 2015
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Laboratory Biomarker Analysis,
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- Selumetinib
-
Tampa, Florida
- +8 more
Jul 24, 2015
Recurrent Melanoma, Stage III Skin Melanoma, Stage IV Skin Melanoma Trial in New York (Laboratory Biomarker Analysis,
Completed
- Recurrent Melanoma
- +2 more
- Laboratory Biomarker Analysis
- Selumetinib
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 16, 2015
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (Akt
Completed
- Pancreatic Acinar Cell Carcinoma
- +3 more
- Akt Inhibitor MK2206
- +3 more
-
Tucson, Arizona
- +533 more
Feb 10, 2016
Healthy Volunteers Pharmacokinetic Study Trial in London (Selumetinib)
Completed
- Healthy Volunteers Pharmacokinetic Study
- Selumetinib
-
London, United KingdomResearch Site
May 30, 2014
Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,
Terminated
- Recurrent Melanoma
- +4 more
- Akt inhibitor MK2206
- +2 more
-
Atlanta, Georgia
- +3 more
May 16, 2014
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +3 more
- selumetinib
- pharmacological study
-
Tampa, Florida
- +5 more
May 12, 2014
Mucosal Melanoma, Recurrent Melanoma, Stage IV Melanoma Trial in Tampa (temsirolimus, selumetinib, laboratory biomarker
Terminated
- Mucosal Melanoma
- +2 more
- temsirolimus
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Apr 29, 2014